Flowserve
FLS
$72.93
-8.81%
Flowserve Corporation is a leading manufacturer and aftermarket service provider of comprehensive flow control systems, operating within the industrial machinery sector. The company is a key player in the global industrial infrastructure market, providing precision-engineered pumps, valves, and seals essential for industries such as oil and gas, chemical processing, power generation, and water management. The current investor narrative centers on the company's execution within a robust industrial capital expenditure cycle, with recent attention focused on its ability to translate strong order backlogs into profitable growth and manage the volatility inherent in its project-driven business, as evidenced by recent quarterly results.…
FLS
Flowserve
$72.93
Investment Opinion: Should I buy FLS Today?
Rating & Thesis: Hold. Flowserve is a Hold due to the compelling conflict between its strong technical/financial health and its prohibitive earnings volatility and premium valuation; investors should await more consistent quarterly execution before committing new capital. This aligns with the mixed analyst sentiment, where some maintain 'Buy' ratings but others, like B of A, have downgraded to 'Neutral'.
Supporting Evidence: The forward P/E of 17.71x is reasonable if earnings materialize, representing a significant discount to the trailing 26.05x. The company's financial foundation is strong, with robust free cash flow of $435 million and a return on equity of 15.8%. However, Q4 revenue growth decelerated to 3.54% YoY, and the stock's 1.91x Price-to-Sales ratio trades at a premium within its sector, demanding superior growth.
Risks & Conditions: The two biggest risks are the continuation of extreme quarterly earnings volatility and a failure to accelerate revenue growth. This Hold would upgrade to a Buy if the company reports two consecutive quarters of stable, growing net income (e.g., >$100 million) and the forward P/E compresses below 16x on sustained momentum. It would downgrade to a Sell if quarterly losses recur, revenue growth turns negative, or the stock breaks below key technical support at $65. Currently, the stock is fairly valued to slightly overvalued relative to its own volatile history, pricing in a smooth earnings recovery that has yet to be demonstrated.
Sign up to view all
FLS 12-Month Price Forecast
The outlook for FLS is balanced with a tilt towards the base case of continued volatility within a range. The forward valuation is not demanding if earnings are delivered, but the company's demonstrated inability to produce consistent quarterly profits is a major overhang. The stock's powerful momentum is a near-term positive but increases vulnerability to a sharp correction on any disappointment. The stance would upgrade to bullish on evidence of quarterly earnings stabilization (two clean quarters) and downgrade to bearish on a breakdown below the $65 support level, which would signal a failure of the current uptrend.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Flowserve's 12-month outlook, with a consensus price target around $94.81 and implied upside of +30.0% versus the current price.
Average Target
$94.81
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$58 - $95
Analyst target range
Analyst coverage for Flowserve appears limited, with only two analysts providing estimates for future EPS and revenue, suggesting it may have lower institutional coverage typical of some mid-cap industrials. The consensus among the few providing ratings, based on recent institutional actions, leans bullish, with firms like Citigroup, Stifel, and Mizuho maintaining 'Buy' or 'Outperform' ratings as recently as February 2026. The average revenue estimate for the forward period is $5.78 billion, with a tight range between $5.75 billion and $5.82 billion, indicating strong conviction in the top-line outlook. The wide dispersion in historical price targets and the limited number of explicit targets in the provided data signal there is still meaningful uncertainty around the stock's fair value, which can lead to higher volatility. The recent downgrade by B of A Securities from 'Buy' to 'Neutral' in November 2025 highlights that not all analysts share the uniformly bullish sentiment, pointing to ongoing debates about execution and cyclical risks.
Bulls vs Bears: FLS Investment Factors
The evidence currently tilts slightly bullish, driven by powerful technical momentum, strong cash generation, and an attractive forward earnings multiple. However, the bear case is formidable, anchored in extreme earnings volatility and a premium trailing valuation that demands flawless execution. The single most important tension in the investment debate is whether the company can stabilize its wildly fluctuating quarterly profits to justify its forward earnings multiple. If Flowserve can demonstrate consistent earnings delivery, the stock could re-rate higher; if quarterly volatility persists, the premium valuation is unsustainable, and the stock will likely correct.
Bullish
- Strong Technical Momentum: The stock has surged 26.88% over the past month, dramatically outperforming the S&P 500's 0.74% gain. This follows a powerful 75.96% one-year price change, indicating sustained and accelerating buying pressure as the stock trades near its 52-week high of $92.41.
- Solid Financial Health & Cash Flow: Flowserve maintains a robust balance sheet with a strong current ratio of 2.03 and a manageable debt-to-equity ratio of 0.80. Most importantly, it generated $435.0 million in trailing twelve-month free cash flow, providing significant liquidity for shareholder returns and strategic investments.
- Attractive Forward Earnings Valuation: The forward P/E ratio of 17.71x is significantly lower than the trailing P/E of 26.05x, signaling the market expects a substantial earnings recovery. This forward multiple is more reasonable for an industrial company and offers a clearer valuation anchor if projected earnings materialize.
- Analyst Conviction in Revenue Outlook: Analysts project forward revenue of $5.78 billion with a very tight range between $5.75B and $5.82B, indicating strong conviction in the top-line stability. This consensus, coupled with recent 'Buy' ratings from Citigroup and Stifel, supports a positive fundamental narrative.
Bearish
- Extreme Quarterly Earnings Volatility: The company swung from a Q3 2025 net income of $219.6 million to a Q4 2025 net loss of $29.0 million. This dramatic 113% sequential decline highlights the project-driven, lumpy nature of the business, making earnings predictability and valuation difficult.
- Decelerating Revenue Growth: Q4 2025 revenue grew only 3.54% year-over-year, a deceleration from stronger prior quarters. This raises concerns about the sustainability of growth within the current industrial cycle and the company's ability to translate its order backlog.
- Premium Trailing Valuation: With a trailing P/E of 26.05x, Flowserve trades at a premium to typical industrial machinery peers. This elevated multiple, combined with a stock price near its 52-week high, leaves little room for error and increases vulnerability to valuation compression if growth disappoints.
- High Volatility & Recent Pullback: The stock's beta of 1.246 indicates it is 25% more volatile than the market. This was evidenced by a sharp pullback from over $92 in February 2026 to near $65 in March 2026, a -30% drawdown, demonstrating significant price risk even within an uptrend.
FLS Technical Analysis
The stock is in a strong, sustained uptrend over the past year, evidenced by a 75.96% one-year price change. As of the latest data, the stock is trading at approximately 88% of its 52-week high of $92.41, positioning it near the upper end of its annual range, which signals strong momentum but also raises questions about potential overextension. The stock's beta of 1.246 indicates it is approximately 25% more volatile than the broader market, a factor investors must account for in risk management. Recent momentum shows significant acceleration, with a 26.88% gain over the past month, sharply outpacing the S&P 500's 0.74% gain, suggesting strong near-term buying pressure. However, this short-term surge contrasts with a more modest 14.43% gain over the past three months, which was slightly below the market's 15.14% return, indicating the stock experienced a period of consolidation before its recent breakout. Key technical levels are clearly defined, with immediate support at the 52-week low of $45.11 and resistance at the 52-week high of $92.41. A decisive breakout above $92.41 would signal a continuation of the powerful uptrend, while a failure to hold recent gains could see a retest of support levels established during the March 2026 pullback near $65.
Beta
1.25
1.25x market volatility
Max Drawdown
-30.0%
Largest decline past year
52-Week Range
$48-$92
Price range past year
Annual Return
+52.5%
Cumulative gain past year
| Period | FLS Return | S&P 500 |
|---|---|---|
| 1m | +4.8% | -1.7% |
| 3m | +0.1% | +13.7% |
| 6m | +2.7% | +6.2% |
| 1y | +52.5% | +20.8% |
| ytd | +3.1% | +7.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
FLS Fundamental Analysis
Revenue growth has been modest but positive, with the most recent Q4 2025 revenue of $1.22 billion representing a 3.54% year-over-year increase. However, this growth is decelerating from the stronger performance seen in prior quarters of 2025, such as Q3's $1.17 billion and Q2's $1.19 billion, indicating potential cyclical headwinds or project timing issues. The company's profitability is volatile on a quarterly basis; while it reported a net loss of $29.0 million in Q4 2025, this followed a strong net income of $219.6 million in Q3 2025. The gross margin for Q4 was a healthy 34.8%, consistent with the trailing twelve-month gross margin of 34.6%, suggesting core pricing and cost control remain stable despite the quarterly net income swing. The balance sheet and cash flow position is solid, with a strong current ratio of 2.03 and a manageable debt-to-equity ratio of 0.80. The company generated substantial free cash flow over the trailing twelve months, totaling $435.0 million, which provides ample liquidity for dividends, share repurchases, and strategic investments. A return on equity of 15.8% indicates efficient use of shareholder capital, supporting the company's financial health.
Quarterly Revenue
$1.2B
2025-12
Revenue YoY Growth
+0.03%
YoY Comparison
Gross Margin
+0.34%
Latest Quarter
Free Cash Flow
$434957000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is FLS Overvalued?
Given the company's positive net income on a trailing basis, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E ratio is 26.05x, while the forward P/E is notably lower at 17.71x, indicating the market expects significant earnings growth in the coming year. Compared to industry averages, Flowserve's trailing P/E of 26.05x trades at a premium, which must be justified by its market position and growth prospects relative to peers. The stock's Price-to-Sales ratio of 1.91x and EV/EBITDA of 14.34x provide additional context for its industrial sector valuation. Historically, the stock's own valuation has fluctuated significantly; the current trailing P/E of 26.05x is above the multi-year range seen in the historical data, which has included periods of negative earnings. Trading near the higher end of its own historical valuation band suggests the market is currently pricing in optimistic expectations for margin recovery and earnings growth following the volatile Q4 result.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -76x~90x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.3x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is extreme earnings volatility, as evidenced by the swing from a $219.6 million profit in Q3 to a $29.0 million loss in Q4 2025. This project-driven lumpiness makes forecasting difficult and can lead to significant earnings misses. While the balance sheet is solid with a 0.80 debt-to-equity ratio, the company's valuation (26.05x trailing P/E) is highly dependent on achieving projected earnings growth, creating downside risk if execution falters. Revenue growth is also decelerating to 3.54% YoY, raising questions about cyclical momentum.
Market & Competitive Risks: The stock trades at a premium trailing P/E multiple compared to industry averages, making it susceptible to valuation compression in a rising rate environment or sector rotation out of industrials. Its beta of 1.246 confirms it is more volatile than the market, amplifying downside moves during broader sell-offs. Competitive risks are inherent in the industrial machinery sector, where pricing pressure and project delays can quickly impact margins and backlog conversion, as suggested by the recent quarterly net loss.
Worst-Case Scenario: The worst-case scenario involves a combination of a cyclical downturn in core oil & gas and chemical end-markets, leading to order cancellations and margin compression, coupled with a failure to manage quarterly project volatility. This could trigger multiple analyst downgrades and a de-rating of the forward P/E. A realistic downside could see the stock retest its 52-week low of $45.11, representing a potential loss of approximately -45% from the current price near $81.70. The historical max drawdown of -30.04% in early 2026 provides a recent precedent for severe, rapid declines.
FAQ
The key risks are, in order of severity: 1) Earnings Volatility Risk: The business is project-driven, causing wild quarterly swings (e.g., $219.6M profit to $29.0M loss), making the stock unpredictable. 2) Valuation Compression Risk: Trading at a 26.05x trailing P/E, the stock is vulnerable to multiple contraction if growth decelerates or interest rates rise. 3) Cyclical Demand Risk: Revenue growth slowed to 3.54% in Q4; a downturn in core oil & gas or chemical markets would hurt orders and margins. 4) Price Volatility Risk: With a beta of 1.246, the stock is 25% more volatile than the market, magnifying losses in downturns.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $78 and $92, as it continues its volatile path but meets full-year earnings estimates near $5.68 per share. The Bull Case (25% probability) targets $92.41 to $105, requiring stable quarterly earnings beats and multiple expansion. The Bear Case (20% probability) warns of a drop to between $45.11 and $65 if cyclical headwinds cause an earnings miss and de-rating. The base case is most likely, anchored on the assumption that annual earnings will meet consensus despite quarterly turbulence, but it does not preclude significant price swings along the way.
FLS sends mixed valuation signals. On a trailing basis, it appears overvalued with a P/E of 26.05x, which is at a premium to industry peers and its own historical range during periods of positive earnings. However, the forward P/E of 17.71x suggests it is fairly valued or even slightly undervalued if the market's earnings growth expectations are met. The Price-to-Sales ratio of 1.91x is also towards the higher end for industrials. Overall, the stock is fairly valued to slightly overvalued, as the current price implies a smooth and significant earnings recovery that the company's volatile history does not guarantee.
FLS presents a high-risk, high-reward proposition. For investors with a high risk tolerance and a tactical approach, it could be a good buy on a pullback towards support (e.g., near $70-75) if they believe in the industrial capex cycle and management's ability to smooth earnings. The 17.71x forward P/E offers reasonable value if projected earnings of $5.68 per share are hit. However, for most investors seeking stability, it is not a good buy due to its extreme quarterly volatility (Q3 profit to Q4 loss), 1.246 beta, and premium trailing valuation. The biggest downside risk is a recurrence of quarterly losses, which could trigger a -30%+ drawdown as seen in March 2026.
FLS is more suitable for medium-term tactical investing (6-18 months) than for long-term buy-and-hold or short-term trading. Its high beta (1.246) and earnings volatility make it a poor fit for short-term traders without high-risk tolerance. For long-term investors, the cyclical nature and lack of consistent earnings growth visibility are drawbacks, though its strong market position is a positive. A minimum holding period of 12-18 months is suggested to potentially ride out a full industrial cycle and allow time for the forward earnings story to play out, but investors must be prepared to actively manage position size due to the stock's inherent volatility.